Anticancer effect of myristicin on hepatic carcinoma and related molecular mechanism |
| |
Authors: | Hailan Bao Qi Muge |
| |
Institution: | aCollege of Traditional Mongolian Medicine, Inner Mongolia University for Nationalities, Tongliao, China;bMengxi Integrative Medicine Division of Respiratory and Critical Care Medicine, Affiliated Hospital of Inner Mongolia University for Nationalities, Tongliao, China |
| |
Abstract: | ContextMyristicin is a natural active compound that has inflammatory, antimicrobial and anti-proliferative properties. Yet, its effect on hepatic carcinoma has not been investigated.ObjectiveTo explore the role and related molecular mechanism of myristicin in hepatic carcinoma in vitro.Materials and methodsHuman hepatic carcinoma cell lines (Huh-7 and HCCLM3 cells) were treated with different concentrations of myristicin (0.5, 1 and 5 mM) for 24, 48 and 72 h. Then, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium assay (MTT), flow cytometer (FCM) analysis and transwell assay were performed to determine cell proliferation, apoptosis and migration/invasion, respectively. Protein levels of B-cell lymphoma-2 (Bcl-2), Bcl-2 associated X (Bax), E-cadherin, N-cadherin and phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signalling pathway-related proteins were detected using Western blot assay. Gene expression was determined using quantitative real time-polymerase chain reaction (qRT-PCR).ResultsMyristicin inhibited cell proliferation and induced apoptosis in Huh-7 and HCCLM3 cells; suppressed cell migration and invasion ability, and increased E-cadherin expression and decreased N-cadherin expression, thereby inhibiting epithelial–mesenchymal transition (EMT). Finally, the findings indicated that myristicin decreased phosphorylated (p)-mTOR and p-AKT expression at the protein level.Discussion and conclusionsMyristicin exerts an efficient therapeutic effect on hepatic carcinoma by suppressing PI3K/Akt/mTOR signalling pathway; thus, it may be used as a new potential drug for hepatic carcinoma treatment. |
| |
Keywords: | PI3K/Akt/mTOR signalling pathway EMT migration invasion proliferation apoptosis |
|
|